NICOLAS MAGALLANES
NICOLAS MAGALLANES is named as a lobbyist in 20 lobbying reports we hold, filed by 1 registrant for 20 clients.
Earlier government jobs, as reported
A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.
- Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander
Registrants and clients
- TODD STRATEGY GROUP · 20 reports
Clients: ALNYLAM PHARMACEUTICALS, INC.; AMERICAN SOCIETY OF NEPHROLOGY; AMGEN INC.; ASTELLAS PHARMA US, INC.; ASTRAZENECA PHARMACEUTICALS LP; BIOGEN, INC.; COMPASS PATHWAYS INC.; ELI LILLY AND COMPANY; FOX CORPORATION; GENENTECH, INC.; JOHNSON & JOHNSON SERVICES, INC.; MCKESSON CORPORATION; MENARINI GROUP; NOVARTIS, INC.; NOVO NORDISK INC.; PFIZER INC.; PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA; SUNBOUND HOMES; TAKEDA PHARMACEUTICALS AMERICA, INC.; THE COALITION FOR 21ST CENTURY MEDICINE.
Bills named where this lobbyist is listed, and how the House and the Senate voted
13 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1672Maintaining Investments in New Innovation Act | Introduced | No recorded vote in our record |
| H.R. 2214DRUG Act | Introduced | No recorded vote in our record |
| H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act | Introduced | No recorded vote in our record |
| H.R. 4312SCORE Act | Reported by committee | No recorded vote in our record |
| H.R. 5376Impacts and Outcomes for Health Career Training Act | Introduced | No recorded vote in our record |
| H.R. 5539POW Priority Care Act of 2025 | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 864HELP Copays Act | Introduced | No recorded vote in our record |
| S. 1040Drug Competition Enhancement Act | Reported by committee | No recorded vote in our record |
| S. 1041Affordable Prescriptions for Patients Act | Passed the Senate | No recorded vote in our record |
| S. 3131USS Frank E. Evans Act | Introduced | No recorded vote in our record |
Issues named: Medicare/Medicaid (13), Health Issues (11), Pharmacy (4), Trade (domestic/foreign) (3), Communications/Broadcasting/Radio/TV (1), Tariff (miscellaneous tariff bills) (1), Taxation/Internal Revenue Code (1).
Every report
| Client | Registrant | Kind, as filed | Posted | Report |
|---|---|---|---|---|
| MENARINI GROUPMedicare/Medicaid | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| TAKEDA PHARMACEUTICALS AMERICA, INC.Health Issues, Medicare/Medicaid, Trade (domestic/foreign) | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| SUNBOUND HOMESMedicare/Medicaid | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAMedicare/Medicaid, Pharmacy | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| PFIZER INC.Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign) | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| NOVO NORDISK INC.Health Issues | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| MCKESSON CORPORATIONMedicare/Medicaid | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| JOHNSON & JOHNSON SERVICES, INC.Health Issues | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| GENENTECH, INC.Pharmacy, Medicare/Medicaid | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| FOX CORPORATIONCommunications/Broadcasting/Radio/TV | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| COMPASS PATHWAYS INC.Health Issues | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| THE COALITION FOR 21ST CENTURY MEDICINEMedicare/Medicaid | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| BIOGEN, INC.Medicare/Medicaid, Health Issues | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ASTRAZENECA PHARMACEUTICALS LPHealth Issues, Medicare/Medicaid | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ASTELLAS PHARMA US, INC.Health Issues, Pharmacy | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| AMGEN INC.Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| AMERICAN SOCIETY OF NEPHROLOGYHealth Issues | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ALNYLAM PHARMACEUTICALS, INC.Medicare/Medicaid | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| NOVARTIS, INC.Health Issues, Medicare/Medicaid, Trade (domestic/foreign) | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov | |
| ELI LILLY AND COMPANYHealth Issues, Medicare/Medicaid | TODD STRATEGY GROUP | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this lobbyist reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.